Patent Assignment
Reel/Frame 061312/0361
Change of Name
Recorded: 2022-08-24
Pages: 3
Assignor
SEATTLE GENETICS, INC.
Executed: 2020-10-06
Assignee
SEAGEN INC.
21823 30TH DR. S.E., BOTHELL, WASHINGTON, 98021
Covered Property
(1)
Methods of Treating HER2 Positive Breast Cancer with Tucatinib in Combination with an Anti-HER2 Antibody-Drug Conjugate
Application:
17/775,492 →
Publication:
US 2022/0387618
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 24, 2022
From: WALKER, LUKE
To: SEATTLE GENETICS, INC.
Reel/Frame 060883/0679 →
Assignment of Assignor's Interest
Aug 24, 2022
From: WALKER, LUKE
To: SEATTLE GENETICS, INC.
Reel/Frame 060883/0760 →
Assignment of Assignor's Interest
Aug 24, 2022
From: RAMOS, JORGE; PARKER, AULMA
To: SEAGEN INC.
Reel/Frame 060884/0111 →
Assignment of Assignor's Interest
Aug 24, 2022
From: KULUKIAN, ANITA
To: SEAGEN INC.
Reel/Frame 060884/0724 →
Assignment of Assignor's Interest
Aug 24, 2022
From: WALKER, LUKE; RAMOS, JORGE; PARKER, AULMA
To: SEAGEN INC.
Reel/Frame 061312/0422 →